These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 9434044)
21. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Jimi E; Nakamura I; Amano H; Taguchi Y; Tsurukai T; Tamura M; Takahashi N; Suda T Endocrinology; 1996 Aug; 137(8):2187-90. PubMed ID: 8754795 [TBL] [Abstract][Full Text] [Related]
22. Insulin-like growth factor-binding protein-2 is required for osteoclast differentiation. DeMambro VE; Maile L; Wai C; Kawai M; Cascella T; Rosen CJ; Clemmons D J Bone Miner Res; 2012 Feb; 27(2):390-400. PubMed ID: 22006816 [TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-I mediates osteoclast-like cell formation stimulated by parathyroid hormone. Kaji H; Sugimoto T; Kanatani M; Nishiyama K; Nasu M; Chihara K J Cell Physiol; 1997 Jul; 172(1):55-62. PubMed ID: 9207925 [TBL] [Abstract][Full Text] [Related]
24. [In vitro effects of growth hormone on osteoclastic activity: clinical applications]. Rousselle AV; Damiens C; Guicheux J; Pilet P; Padrines M; Heymann D Rev Chir Orthop Reparatrice Appar Mot; 2000 May; 86(3):256-64. PubMed ID: 10844356 [TBL] [Abstract][Full Text] [Related]
25. GH/IGF-I and bone resorption in vivo and in vitro. Ueland T Eur J Endocrinol; 2005 Mar; 152(3):327-32. PubMed ID: 15757846 [TBL] [Abstract][Full Text] [Related]
26. Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study. Brixen K; Kassem M; Nielsen HK; Loft AG; Flyvbjerg A; Mosekilde L J Bone Miner Res; 1995 Dec; 10(12):1865-74. PubMed ID: 8619366 [TBL] [Abstract][Full Text] [Related]
27. Differences in the fusion and resorption activity of human osteoclasts after stimulation with different growth factors released from a polylactide carrier. Wildemann B; Kadow-Romacker A; Lübberstedt M; Raschke M; Haas NP; Schmidmaier G Calcif Tissue Int; 2005 Jan; 76(1):50-5. PubMed ID: 15477999 [TBL] [Abstract][Full Text] [Related]
28. Carboxyl-terminal parathyroid hormone fragments stimulate osteoclast-like cell formation and osteoclastic activity. Kaji H; Sugimoto T; Kanatani M; Miyauchi A; Kimura T; Sakakibara S; Fukase M; Chihara K Endocrinology; 1994 Apr; 134(4):1897-904. PubMed ID: 8137758 [TBL] [Abstract][Full Text] [Related]
29. Osteoclast progenitor cells present in significant amounts in mouse calvarial osteoblast isolations and osteoclastogenesis increased by BMP-2. Granholm S; Henning P; Lindholm C; Lerner UH Bone; 2013 Jan; 52(1):83-92. PubMed ID: 23017661 [TBL] [Abstract][Full Text] [Related]
30. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated. Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799 [TBL] [Abstract][Full Text] [Related]
31. Vasoactive intestinal peptide regulates osteoclast activity via specific binding sites on both osteoclasts and osteoblasts. Lundberg P; Lie A; Bjurholm A; Lehenkari PP; Horton MA; Lerner UH; Ransjö M Bone; 2000 Dec; 27(6):803-10. PubMed ID: 11113391 [TBL] [Abstract][Full Text] [Related]
32. Evidence that IGF-binding protein-5 functions as a growth factor. Miyakoshi N; Richman C; Kasukawa Y; Linkhart TA; Baylink DJ; Mohan S J Clin Invest; 2001 Jan; 107(1):73-81. PubMed ID: 11134182 [TBL] [Abstract][Full Text] [Related]
33. Insulin-like growth factor I does not stimulate bone resorption in cultured neonatal mouse calvarial bones. Jonsson KB; Wiberg K; Ljunghall S; Ljunggren O Calcif Tissue Int; 1996 Nov; 59(5):366-70. PubMed ID: 8849403 [TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells. Slootweg MC; Ohlsson C; Salles JP; de Vries CP; Netelenbos JC Endocrinology; 1995 Oct; 136(10):4210-7. PubMed ID: 7545101 [TBL] [Abstract][Full Text] [Related]
35. Basic fibroblast growth factor regulates IGF-I binding proteins in the clonal osteoblastic cell line MC3T3-E1. Hurley MM; Abreu C; Hakeda Y J Bone Miner Res; 1995 Feb; 10(2):222-30. PubMed ID: 7538725 [TBL] [Abstract][Full Text] [Related]
36. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction. Kanatani M; Sugimoto T; Sowa H; Kobayashi T; Kanzawa M; Chihara K J Cell Physiol; 2004 Oct; 201(1):17-25. PubMed ID: 15281085 [TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor I and insulin down-regulate growth hormone (GH) receptors in rat osteoblasts: evidence for a peripheral feedback loop regulating GH action. Leung K; Rajkovic IA; Peters E; Markus I; Van Wyk JJ; Ho KK Endocrinology; 1996 Jul; 137(7):2694-702. PubMed ID: 8770888 [TBL] [Abstract][Full Text] [Related]
38. A differentiation-inducing factor produced by the osteoblastic cell line MC3T3-E1 stimulates bone resorption by promoting osteoclast formation. Abe E; Ishimi Y; Takahashi N; Akatsu T; Ozawa H; Yamana H; Yoshiki S; Suda T J Bone Miner Res; 1988 Dec; 3(6):635-45. PubMed ID: 3266954 [TBL] [Abstract][Full Text] [Related]